Cohanzick Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Cohanzick Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,077	Closed	-$11K	–	381
2022 Q2	$11K	Sell	1,077 -140	-12%	-$1.38K	﹤0.01%	331
2022 Q1	$12K	Hold	1,217	–	–	﹤0.01%	398
2021 Q4	$11.9K	Buy	+1,217	New	+$11.9K	﹤0.01%	396

Other funds holding FLAC

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Cohanzick Management's FLAC Position: Q3 2022 in Review

Cohanzick Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q3 2022, closing a stake of 1,077 shares — an estimated $11K sold.

Cohanzick Management first reported a position in FLAC in Q4 2021 and held it in 3 quarters. The position peaked at $12K in Q1 2022. 52 funds tracked by Wall St. Rank hold FLAC as of Q3 2022.

Cohanzick Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Cohanzick Management sold 1,077 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q3 2022, an estimated $11K.
Cohanzick Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 3 quarters.
Cohanzick Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $12K in Q1 2022.
52 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q3 2022.

Based on Cohanzick Management's 13F filing for Q3 2022, filed 10 Nov 2022.